Anti-BP180 autoantibody values were significantly higher in the stroke group (19.2 ± 6.07 U/ml) compared to those in the control group by ELISA (12.2 ± 2.39 U/ml; P = 0.024). This evidence concerns the gene COL17A1 and Stroke.